Orchid Pharma share price has plunged 5% and is presently trading at Rs 1,442.0.
Meanwhile, the BSE HEALTHCARE index is at 42,941.3 (down 0.5%).
Among the top losers in the BSE HEALTHCARE index today are GRANULES INDIA (down 4.1%) and Dr. Reddys (down 2.6%).
Pfizer (up 4.5%) and MAX HEALTHCARE INSTITUTE (up 1.7%) are among the top gainers today.
Over the last one year, Orchid Pharma has moved up from Rs 549.1 to Rs 1,442.0, registering a gain of Rs 893.0 (up 162.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,815.8 to 42,941.3, registering a gain of 54.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.2%), Glenmark Pharma (up 124.1%) and SUVEN PHARMACEUTICALS (up 112.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,455.4 (up 0.1%).
The top gainers among the BSE Sensex today are Bajaj Finserv (up 3.4%) and HCl Tech. (up 3.0%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 25,256.5 (up 0.1%). Bajaj Finserv and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,075.8 to 82,455.4, registering a gain of 17,379.6 points (up 26.7%).
Orchid Pharma net profit grew 162.4% YoY to Rs 283 million for the quarter ended June 2024, compared to a profit of Rs 108 million a year ago. Net sales rose 33.6% to Rs 2,444 million during the period as against Rs 1,829 million in April-June 2023.
For the year ended March 2024, Orchid Pharma reported 72.1% increase in net profit to Rs 951 million compared to net profit of Rs 552 million during FY23. Revenue of the company grew 23.0% to Rs 8,194 million during FY24.
The current Price to earnings ratio of Orchid Pharma, based on rolling 12 month earnings, stands at 65.3.
Equitymaster requests your view! Post a comment on "Orchid Pharma Plunges 5%; BSE HEALTHCARE Index Down 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!